Indian equity markets staged a recovery on Monday, supported by softer-than-expected US jobs data and a moderation in crude oil prices, providing some relief to investors assessing the near-term interest rate outlook. Technically, the Nifty tested its broken weekly 200-SMA zone at 22,580-22,600 but closed below the band.

A sustained move above this zone could extend the recovery towards 22,800, while rejection could keep 22,400 as the immediate support, according to Hariselvan Radhakrishnan, Founder & CEO of HST Wealth. Against this backdrop, Vedanta, Kotak Mahindra Bank, Marico, Axis Bank, Trent, Zydus Lifesciences and other stocks are likely to remain in focus on Tuesday following key corporate developments and business updates.

VedantaAnil Agarwal-led metals and mining major Vedanta Ltd is set to consider its first interim dividend for the financial year 2026-27. The company's Board of Directors is scheduled to meet on Thursday, October 8, 2026, to consider and approve the first interim dividend on equity shares, if any, for FY27.

Vedanta has fixed Wednesday, October 14, 2026, as the record date for determining the entitlement of equity shareholders to the proposed dividend, if declared. TrentTata Group's retail arm Trent reported a 23% year-on-year increase in standalone revenue from operations, excluding GST, to Rs 5,788 crore for the quarter ended September 30, 2026, compared with Rs 4,724 crore in the year-ago period, according to its exchange filing.

For the first half of FY27, revenue rose 21% year-on-year to Rs 11,454 crore from Rs 9,505 crore in the corresponding period a year earlier. 09% stake from its founders and certain other shareholders.

18% stake in Satiya Nutraceuticals on a fully diluted basis, in tranches, from its founders and certain other shareholders, in line with the terms and conditions agreed under the definitive agreements. 284 lakh crore a year earlier, according to the lender's exchange filing.

729 lakh crore at the end of June 2026. 035 lakh crore a year earlier.

729 lakh crore at the end of June 2026.. 37 sq ft.

7% year-on-year increase in net advances to Rs 5,77,094 crore as of September 30, 2026, compared with Rs 4,62,688 crore a year earlier. 7% from Rs 5,12,249 crore at the end of June 2026, according to the lender's exchange filing.

5% sequentially. GAILGAIL has appointed Rajeev Kumar as a Non-Executive Director of the company with effect from October 1, 2026.